Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage
- 1 September 2016
- journal article
- Published by Elsevier in Biomaterials
- Vol. 102, 209-219
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AR061564, DK103581)
This publication has 44 references indexed in Scilit:
- Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated DamagePLOS ONE, 2013
- Use of Mesenchymal Stem Cells (MSC) in Chronic Inflammatory Fistulizing and Fibrotic Diseases: a Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2013
- Myeloid Suppressor Cells Induced by Retinal Pigment Epithelial Cells Inhibit Autoreactive T-Cell Responses That Lead to Experimental Autoimmune UveitisInvestigative Ophthalmology & Visual Science, 2012
- Application of MultiStem® Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host DiseaseFrontiers in Immunology, 2012
- Mesenchymal Stem CellsCirculation Research, 2011
- Mesenchymal Stem Cells Inhibit Complement Activation by Secreting Factor HStem Cells and Development, 2010
- Role of DAF in Protecting against T-Cell Autoreactivity that Leads to Experimental Autoimmune UveitisInvestigative Ophthalmology & Visual Science, 2009
- Structural stability and heat‐induced conformational change of two complement inhibitors: C4b‐binding protein and factor HProtein Science, 2004
- Inhibition of neutrophil oxidative burst and granule secretion by Wortmannin: Potential role of MAP kinase and renaturable kinasesJournal of Cellular Physiology, 1997
- Activation of human neutrophils by C3a and C5A Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burstFEBS Letters, 1994